CIK 0001137883 · Non-accelerated filer<br>Smaller reporting company
BRAINSTORM CELL THERAPEUTICS INC.
Sign in to watch- Ticker
- BCLI
- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 207273918
- Phone
- 201-488-0460
- Business address
- 1325 AVENUE OF AMERICAS, 28TH FLOOR, NEW YORK, NY, 10019
- Former names
- BRAINSTORM CELL THERAPEUTICS INC, GOLDEN HAND RESOURCES INC, WIZBANG TECHNOLOGIES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-12-10 | FRENKEL JACOB A Director | Grant or award · Stock Option (right to buy) | +50,000 | 50,000 | ||
| 2021-12-10 | Abbhi Sankesh Director | Grant or award | +6,666 | 11,323 | ||
| 2021-12-10 | Yablonka Uri Director | Grant or award · Stock Option (right to buy) | +13,333 | 13,333 | ||
| 2021-12-10 | Almenoff June Sherie Director | Grant or award | +2,000 | 4,000 | ||
| 2020-12-30 | Shah Preetam EVP, CFO and Treasurer | Shares withheld for taxes | −25,000 | $4.64 | $116K | 11,600 |
| 2020-11-17 | Lindborg Stacy EVP, Head Global Clin Research | Purchase · Call Option (right to buy) | +200 | $11,000.00 | $2.2M | 200 |
| 2020-09-08 | Waclawski Anthony See Remarks | Grant or award | +35,000 | 35,000 | ||
| 2020-09-08 | Waclawski Anthony See Remarks | Grant or award · Stock Option (Right to Buy) | +80,000 | 80,000 | ||
| 2020-07-26 | Lebovits Chaim Chief Executive Officer | Grant or award | +31,185 | 124,740 | ||
| 2020-07-16 | Setboun David EVP and COO | Purchase | +5,000 | $12.95 | $65K | 55,000 |
| 2020-07-16 | ACC International Holdings Ltd. Member of 10% owner group | Sale | −7,823 | $13.47 | $105K | 67,053 |
| 2020-07-15 | Abbhi Sankesh Director | Purchase | +46,779 | $12.99 | $608K | 2,164,530 |
| 2020-07-15 | ACC International Holdings Ltd. Member of 10% owner group | Sale | −18,430 | $13.12 | $242K | 74,876 |
| 2020-07-13 | ACC International Holdings Ltd. Member of 10% owner group | Sale | −40,000 | $13.52 | $541K | 93,306 |
| 2020-07-10 | ACC International Holdings Ltd. Member of 10% owner group | Sale | −2,000 | $13.35 | $27K | 133,306 |
| 2020-07-09 | ACC International Holdings Ltd. Member of 10% owner group | Sale | −3,500 | $13.13 | $46K | 135,306 |
| 2020-06-23 | Yablonka Uri EVP & Chief Business Officer | Grant or award | +10,000 | 17,543 | ||
| 2020-06-01 | Lindborg Stacy EVP, Head Global Clin Research | Grant or award | +25,000 | 25,000 | ||
| 2020-06-01 | Lindborg Stacy EVP, Head Global Clin Research | Grant or award · Stock Option (right to buy) | +100,000 | 100,000 | ||
| 2020-04-07 | Setboun David EVP and COO | Grant or award | +50,000 | 50,000 |
Page 5 of 7 · 127 trades